S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes

Coronavirus disease 2019 (COVID-19) has a broad range of clinical manifestations, highlighting the need for specific diagnostic tools to predict disease severity and improve patient prognosis. Recently, calprotectin (S100A8/A9) has been proposed as a potential biomarker for COVID-19, as elevated ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellett, Leah, Khader, Shabaana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520505/
https://www.ncbi.nlm.nih.gov/pubmed/34728150
http://dx.doi.org/10.1016/j.cytogfr.2021.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520505/
https://www.ncbi.nlm.nih.gov/pubmed/34728150
http://dx.doi.org/10.1016/j.cytogfr.2021.10.004

Ejemplares similares